Nordea Investment Management Ab Bausch Health Companies Inc. Transaction History

Nordea Investment Management Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $129,423 - $301,622	-9,971 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$18.89 - $31.89 $103,895 - $175,395	-5,500 Reduced 35.55%	9,971 $295,000
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $94,392 - $121,670	4,600 Added 42.31%	15,471 $391,000
Q1 2019 May 20, 2019	BUY	$20.23 - $26.29 $28,322 - $36,806	1,400 Added 14.78%	10,871 $359,000
Q4 2018 Feb 19, 2019	BUY	$17.64 - $28.32 $167,068 - $268,218	9,471 New	9,471 $239,000
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $167,068 - $268,218	-9,471 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $195,481 - $243,120	9,471 New	9,471 $314,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.72B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.